Finnish and Nordic Lung Cancer Insights – October Update
This overview compiles recent Finnish and Nordic research in lung cancer. The Finnish studies address surgical outcomes during the COVID-19 pandemic, real-world genomic profiling and actionable mutations in advanced disease, national guideline implementation for chemoradiotherapy, and the feasibility of low-dose CT screening for early detection. Nordic collaborative studies provide comparative registry-based analyses of epidemiology, treatment pathways, and survival across Denmark, Finland, Norway, and Sweden.
